Page 32 - Exact Sciences News Today

/PRNewswire/ -- Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space...

Benchmark Co. analyst Bruce Jackson reiterated a Buy rating on Beauty Health (SKIN – Research Report) today and set a price target of $23....

Exact Sciences, a provider of cancer screening and diagnostic tests, has entered into an agreement to acquire Resolution Biosciences.

Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare...

Frontier Capital Management Co. LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 747,966 shares of the medical research company’s stock after selling […]

Recovery from the COVID-19 emergency, higher costs and workforce concerns are among issues compelling medical systems and hospitals to merge with or acquire other systems. The trick is changing while

Sandler Capital Management purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 67,181 shares of the medical research company’s stock, valued at approximately $4,556,000. A number of other […]

Health care delivery systems in Wisconsin and across the nation are changing — and rapidly, in many cases. Recovery from the COVID-19 emergency, higher costs and workforce concerns are among

The company's fight against cancer is only beginning.

The month-long tour intends to "mobilize young people" on key issues that tend to have an outsized impact on them, the White House said in a statement.